IMMU-18. HUMANIZED ANTI-CD47 ANTIBODY COMBINED WITH AN AGONIST ANTI-CD40 ANTIBODY IS AN EFFECTIVE TREATMENT FOR DIPG XENOGRAFTS WITH CRANIOSPINAL DISSEMINATION

INTRODUCTION: DIPG is the most common malignant brainstem tumor in children. The resistance of DIPG to standard treatments along with inoperability of this tumor because of the anatomical location leave DIPG patients with dismal prognosis. Multiple studies revealed that DIPG patients have only a few...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Gholamin, Sharareh, Kahn, Suzana, Esparza, Rogelio, Weissman, Irving, Mitra, Siddhartha, Cheshier, Samuel
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475118/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.128
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires